Literature DB >> 28984590

Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness.

Elizabeth Finger1,2, Jing Zhang2, Bradford Dickerson3, Yves Bureau2, Mario Masellis4,5,6.   

Abstract

Neuropsychiatric symptoms in Alzheimer's disease are among the most disabling and difficult aspects for caregivers and treating health professionals to manage. Despite the high prevalence of these behaviors, little is known about the factors which lead some patients to develop florid behavioral symptoms while others may progress to severe dementia without such phenomenon. We examined whether regional brain volumes as measured by cortical thickness would predict the presence or absence of disinhibition in patients with Alzheimer's disease. Using data from the ADNI, we identified 758 patients with caregiver ratings on the Neuropsychiatric Inventory and a volumetric MRI scan with cortical thickness measurements completed in FreeSurfer by the UCSF core. Of these, 177 patients were found to have disinhibition. Logistic regression models demonstrated that reduced cortical thickness in the right frontal pole was associated with the presence of disinhibition even when controlling for age, disease severity, total intracranial volume, gender, and APOE genotype. The results are considered in the context of leading models of the functions of frontopolar cortex.

Entities:  

Keywords:  Alzheimer’s disease; disinhibition; frontopolar cortex

Mesh:

Substances:

Year:  2017        PMID: 28984590     DOI: 10.3233/JAD-170348

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

Review 1.  Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer's disease: A systematic review and meta-analysis.

Authors:  Shaun Kuan Wei Hiu; Theophile Bigirumurame; Patience Kunonga; Andrew Bryant; Manjunadh Pillai
Journal:  Brain Behav       Date:  2022-08-08       Impact factor: 3.405

2.  White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Philippe Desmarais; Andrew F Gao; Julia Keith; Mario Masellis; Krista Lanctôt; Ekaterina Rogaeva; Joel Ramirez; Nathan Herrmann; Donald T Stuss; Sandra E Black
Journal:  Alzheimers Res Ther       Date:  2021-07-13       Impact factor: 6.982

Review 3.  Cognitive and behavioural inhibition deficits in neurodegenerative dementias.

Authors:  Raffaella Migliaccio; Delphine Tanguy; Arabella Bouzigues; Idil Sezer; Bruno Dubois; Isabelle Le Ber; Bénédicte Batrancourt; Valérie Godefroy; Richard Levy
Journal:  Cortex       Date:  2020-08-10       Impact factor: 4.027

4.  Metabolite Profile of Alzheimer's Disease in the Frontal Cortex as Analyzed by HRMAS 1H NMR.

Authors:  Yuzhong Zhang; Zhou Liu; Bing Ji; Lijian Liu; Shaoxiong Wu; Xiaowu Liu; Silun Wang; Liya Wang
Journal:  Front Aging Neurosci       Date:  2019-01-09       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.